Risks factors for highly unstable response to oral anticoagulation: a case-control study.
about
Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysisGuidance for the practical management of warfarin therapy in the treatment of venous thromboembolismCurrent issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.Risk factors for nonadherence to warfarin: results from the IN-RANGE study.Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.[Evaluation of the level of knowledge of patients on treatment with vitamin K antagonists in Ouagadougou cardiology department]Using highly variable warfarin dosing to identify patients at risk for adverse events.Incidence, clinical impact and risk of bleeding during oral anticoagulation therapyDoes a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial.Contribution of CYP2C9 to variability in vitamin K antagonist metabolism.EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.Role of pharmacogenomics in the management of traditional and novel oral anticoagulantsDemonstration of anticoagulation patient self-testing feasibility at an Indian Health Service facility: A case series analysis.Telephone-based anticoagulation management in the homebound setting: a retrospective observational study.Secondary prevention in thrombotic antiphospholipid syndrome.Clinical pharmacogenomics of warfarin and clopidogrel.Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein Thrombosis.Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.Comparison of three medication adherence measures in patients taking warfarin.Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists.
P2860
Q26852661-FBC22F3C-3360-40CC-8095-D39B9F5D8ADFQ28066527-24EFBEC3-67F4-40F4-B5B6-734947462DFCQ33755738-B771931F-72B1-4561-B3F9-D701C18AD4ACQ34056085-F8770260-ACB1-4724-A1CD-C4090DC37A77Q34056113-E99C6CDB-0336-4E99-8756-FDF47248E1A5Q34252907-8815FD16-95DC-45BD-80B8-694E0A3B9A16Q34834319-CAC0EFD6-E40C-4F51-B03B-EF53E8399D2AQ35347259-3E849C52-5E7F-41E8-9DA3-C44EBEBE4E55Q35415257-D8746E1A-8F25-4632-8095-814A9FC5D757Q35575180-AE6D96D5-56A3-423E-8F3E-A6C63BA04808Q36271953-826A6EBE-D64F-447A-A9D6-84B48FFB8A8BQ36545011-C57577E2-82AD-4835-8B9C-6763B26FA19FQ36841217-D3D6747D-B2D6-428D-8CBB-7CB03862226AQ36848449-6A940B48-519B-42C6-9A2F-7623EE21F41AQ37190945-7673BE5A-1A87-47B3-B9F5-AAA67E8400F7Q37378325-F92AE6C3-2755-4C12-AD54-8B10F09C711CQ38013589-7FE6B5B7-26DB-440B-BAE3-F870CC9A6476Q38016848-35F3B330-E89D-4652-B574-62CB7C0C7063Q38156339-E83BAD43-E912-4F77-A9F3-0527F7A919BBQ39309926-06DF7948-4D62-4C45-9377-558892655FE2Q39890593-0009914F-B3B2-45B3-8678-13F1492C5320Q45912217-386C8DF6-2635-4A01-A567-0CE875172FAFQ53156908-CFEE7A13-1A83-46BC-84B3-6E29A17AB251
P2860
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@ast
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@en
type
label
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@ast
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@en
prefLabel
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@ast
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@en
P2093
P2860
P1476
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
@en
P2093
Barbara Lunghi
Benilde Cosmi
Daniela Poli
Giovanna Marchetti
Giuliana Guazzaloca
Gualtiero Palareti
Valdré Lelia
ad hoc Study Group of the Italian Federation of Anticoagulation Clinics*
P2860
P356
10.1111/J.1365-2141.2005.05417.X
P407
P577
2005-04-01T00:00:00Z